Clinical Trial Update: ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating tranexamic acid for epistaxis in patients with hereditary hemorrhagic telangiectasia (Osler-Rendu).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis
• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Telangiectasia, Hereditary Hemorrhagic, Osler-Rendu Disease | Phase 3 | Status: COMPLETED